Page 111 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 111
References
1. Munk AC, Gudlaugsson E, Ovestad IT, et al. Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression. Gynecol Oncol. 2012 Dec;127(3):489-94.
2. Trimble CL, Piantadosi S, Gravitt P, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res. 2005 Jul 1;11(13):4717-23.
3. Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol. 2003 Nov;102(5 Pt 1):1058-62.
4. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric
outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: 5 systematic review and meta-analysis. Lancet. 2006 Feb 11;367(9509):489-98.
5. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999 Feb 3;91(3):252-8.
6. McAllum B, Sykes PH, Sadler L, Macnab H, Simcock BJ, Mekhail AK. Is the treatment of CIN 2 always necessary in women under 25 years old? Am J Obstet Gynecol. 2011 Nov;205(5):478 e1-7.
7. Committee on Adolescent Health C. ACOG Committee Opinion No. 436: evaluation and management of abnormal cervical cytology and histology in adolescents. Obstet Gynecol. 2009 Jun;113(6):1422-5.
8. Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27.
9. Kinney W, Hunt WC, Dinkelspiel H, et al. Cervical excisional treatment of young women: a population-based study. Gynecol Oncol. 2014 Mar;132(3):628-35.
10. Koeneman MM, Kruitwagen RF, Nijman HW, Slangen BF, Van Gorp T, Kruse AJ. Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers. Expert Rev Mol Diagn. 2015 Apr;15(4):527-46.
11. Steyerberg EW, Moons KG, van der Windt DA, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.
12. Harell FJ. Regression Modeling Strategies. New York: NY: Springer; 2001.
13. Rositch AF, Soeters HM, Offutt-Powell TN, Wheeler BS, Taylor SM, Smith JS. The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic
review. Gynecol Oncol. 2014 Mar;132(3):767-79.
14. Quint KD, de Koning MN, Quint WG, Pirog EC. Progression of cervical low grade squamous
intraepithelial lesions: in search of prognostic biomarkers. Eur J Obstet Gynecol Reprod Biol.
2013 Oct;170(2):501-6.
15. Fu Y, Chen C, Feng S, et al. Residual disease and risk factors in patients with high-grade
cervical intraepithelial neoplasia and positive margins after initial conization. Ther Clin Risk Manag. 2015;11:851-6.
A prediction model for CIN2 prognosis
109